{
    "SPADE_UN_26575": {
        "Sequence Information": {
            "Peptide Name": "Globomycin 51",
            "Sequence": "XXXX",
            "Sequence Length": 4,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anticancer"
            ],
            "Binding Target": "1. Membrane Protein\n2. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "Optimization of globomycin analogs as novel gram-negative antibiotics.",
                    "Pubmed ID": "32768648",
                    "Reference": "Bioorg Med Chem Lett. 2020;30:127419",
                    "Author": "Garland K, Pantua H, Braun MG, Burdick DJ, Castanedo GM, Chen YC, Cheng YX, Cheong JW, Daniels B, Deshmukh G, Gibbons P, Gloor SL, Hua R, Labadie S, Liu X, Pastor R, Stivala C, Xu M, Xu Y, Zheng H, Kapadia SB, Hanan EJ",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/32768648"
                }
            ],
            "SPADE ID": "SPADE_UN_26575",
            "Similar Sequences": [],
            "Hemolytic Activity": "",
            "Target Organism": "Escherichia coli CFT073(MIC=3.1µM),Escherichia coli CFT073imp4213(MIC=0.048µM),Staphylococcus aureus USA 300(MIC=50µM),Enterobacter cloacae ATCC 13047(MIC=6.3µM),Klebsiella pneumoniae ATCC 700603(MIC=18µM),Pseudomonas aeruginosa PA14(MIC=100µM),Acinetobacter baumannii ATCC 17978(MIC=18µM),Jurkat cancer cells(EC50=>100µM)"
        }
    }
}